First Light Asset Management, LLC Ngm Biopharmaceuticals Inc Transaction History

First Light Asset Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$12.59 - $17.67 $2.27 Million - $3.19 Million	-180,379 Reduced 15.88%	955,505 $12.5 Million
Q2 2022 Aug 12, 2022	BUY	$10.58 - $17.5 $3.38 Million - $5.59 Million	319,231 Added 39.09%	1,135,884 $14.6 Million
Q1 2022 May 13, 2022	BUY	$13.81 - $18.6 $3.39 Million - $4.57 Million	245,755 Added 43.05%	816,653 $12.5 Million
Q4 2021 Feb 14, 2022	BUY	$17.26 - $22.02 $9.85 Million - $12.6 Million	570,898 New	570,898 $10.1 Million

2.6M

300

Ticker NGM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,365,904
Description
NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...

Get notified when there are updates to the investment portfolio of First Light Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on First Light Asset Management, LLC with notifications on news.